Evidence map›Paper›PMID 40719800›Full record

ArticleAnnals of surgical oncology2025

The Real Safety Net Hospitals: High-Medicaid Hospitals Confer Worse Survival for Patients Undergoing Pancreas and Biliary Cancer Surgery.

Anays Murillo, Sing Chau Ng, Sarah M Schroter, Jennifer F Tseng, Kelly Kenzik, Teviah E Sachs

Abstract read
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anays MurilloDepartment of Surgery, Boston Medical Center, Boston, MA, USA.
Sing Chau NgDepartment of Surgery, Boston Medical Center, Boston, MA, USA.
Sarah M SchroterBoston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Jennifer F TsengBoston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Kelly KenzikDepartment of Surgery, Boston Medical Center, Boston, MA, USA.
Teviah E SachsDepartment of Surgery, Boston Medical Center, Boston, MA, USA. Teviah.Sachs@bmc.org.ORCID http://orcid.org/0000-0002-8560-3606

Funding

Clinical and Laboratory Research Training for Surgical OncologistsT32CA126607 · NCI · JOHNS HOPKINS UNIVERSITY · PI CAMERON, ANDREW M. · 2008 to 2024
$6.0M
Understanding rural mortality disparities in cancer: a multi-level approachR37CA266193 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KELLY KENZIK · 2022 to 2026
$1.8M
HRSA HHS T32HP10028NCI NIH HHS R37 CA266193NCI NIH HHS T32 CA126607
6 · The paper itself

Abstract

backgroundLarge-database cancer research often defines hospitals servicing a threshold number of Medicaid patients "safety net"; however, counts are generally with the cancer of interest, and because sufficient rare/complex cases such as hepatobiliary/pancreatic (HPB) cancers tend to be managed at larger institutions, "safety net" may be skewed toward academic centers. Recent data show similar survival for "safety net" HPB care. We examine patterns/outcomes of curative intent surgery (CIS) for HPB cancers by a more comprehensive Medicaid-serving (AID) status utilizing all alimentary tract cancers to generate AID quartiles. PATIENTS AND

methodsWe identified all alimentary tract cancers (NCDB: 2004-2021) to determine quartile proportions of Medicaid-insured patients. Stage I-III primary HPB cancers were analyzed by highest quartile of AID facility ("high-AID") versus remaining quartiles ("low-AID"). Logistic regression identified predictors for undergoing CIS. Cox proportional regression modeled survival. P < 0.01 was significant.

resultsHPB cancer cases totaled 286,873. High-AID patients were more likely to be non-white and have low income/education. Patients were less likely to undergo CIS at high-AID programs (hepatic [H]: OR 0.83, 95% CI 0.80-0.86; pancreas [P]: OR 0.81, 95% CI 0.78-0.84; biliary [B]: OR 0.83, 95% CI 0.79-0.87). Multivariable analyses showed similar survival at 1 and 5 years for hepatic resection at high-AID facilities (1 year: HR 1.01 [0.89-1.14]; 5 years: HR 1.01 [0.95-1.07]). High-AID for pancreatic/biliary patients had greater mortality risk at 1 and 5 years.

conclusionsIncluding more hospitals to define AID status revealed worse survival at high-Medicaid-serving facilities for pancreatic/biliary, but not hepatic cancer surgery patients. Our "safety net hospital" proxy (high-AID) allows for better care disparity identification for complex underserved patients with cancer.

Identifiers

PMID40719800
PMCPMC13682434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.